乌鸦传媒

Greg Laub

Greg Laub

Authors >

Greg Laub

Greg Laub joined 乌鸦传媒 in 2005 as Production Manager and led the launch of the video department in 2007. He currently leads the video and podcast production teams. Greg's passion to craft a story began as a writer, with stops as Managing Editor at USOpen.org, Creative Director at Bernard Hodes Advertising, and copywriter at AOL Time Warner. He's even had one of his screenplays produced -- he believes it was beloved by all seven people who saw it. Greg lives in New Jersey with his wife, two kids and two dogs.

Connect:

email image

Latest from Greg Laub

<乌鸦传媒>The Link Between Tear Polyunsaturated Fatty Acids, Eicosanoids, and Dry Eye

Revisiting old interventions can inspire new interventions, says Anat Galor, MD

<乌鸦传媒>Managing the Safety of Newer Atopic Dermatitis Treatments

Our panel of experts discuss how they monitor patients on biologics and JAK inhibitors

<乌鸦传媒>Biologics Offer New Options in Atopic Dermatitis

Peter Lio, MD, says he can't wait to have more flexibility for his pediatric patients

<乌鸦传媒>Combining Immunotherapy and PARP Inhibition in Advanced Uterine Cancer

And our roundtable of experts discuss selinexor for wild-type p53 disease

<乌鸦传媒>Experts' Hopes for the Future of dMMR Uterine Cancer Treatment

Could this subset eventually be treated without chemotherapy?

<乌鸦传媒>New Data on Bimekizumab in Psoriatic Arthritis

Roundtable of experts weigh in on "unprecedented" efficacy, and safety issues

<乌鸦传媒>Investigational Gene Tx Improves Diabetic Retinopathy Severity at 1 Year

One-time injection demonstrated 89% reduction of vision-threatening events

<乌鸦传媒>Ubamatamab Shows Some Activity in Recurrent Ovarian Cancer

Response rates of 14% alone and 18% in combination with checkpoint inhibitor

<乌鸦传媒>Simplified Assessment Tool for Psoriatic Arthritis Performs Well

Philip Mease, MD, says this new instrument could be reliable in clinical practice

<乌鸦传媒>Biologic Therapy for IBD Not Tied to Higher Risk of Major Heart Events

Newer agents also associated with lower VTE risk versus non-advanced treatments

鈥�

15

鈥�